& Nbspgabriela galvin
Was published
Advertising
According to the new analysis of herpes vaccine.
Researchers studied data from 19 existing studies and found that adults who were vaccinated against Zoster herpes, usually known as tiles, had an 18% lower risk of serious heart problems.
Among people aged 50 years and older, risk decrease was 16%.
It is worth noting that the GSK pharmaceutical giant, which is preparing a vaccine against herpes Zoster, financed the study, and the results have not yet been published in a scientific journal with judges.
Dr. Charles Williams, one of the authors of the study and deputy medical director around the world around the world – vaccine in GSK, said that the results were “encouraging”.
“We examined the currently available data and found that in this analysis, vaccination against (tiles) is associated with a lower risk of cardiovascular events, such as heart attacks or strokes,” he said in his statement.
Zoster, which causes a painful rash of liquid blisters that can take weeks to disappear, is caused by the virus of chickenpox, which also causes chickenpox.
Previous studies They showed that Herpes Zost increases the risk of stroke and heart attack, possibly causing inflammation and destroying blood vessels. This prompted scientists to wonder if vaccination can limit these dangers.
There are two types of vaccine against tiles: a recombinant vaccine against tiles (RZV) and a lively disturbed vaccine against Zoster (ZVL). According to the study, people who were vaccinated, more likely, developed problems with the heart, regardless of which vaccine they made.
However, Williams also referred to some restrictions on analysis. Most of the data came from observations, which means that they cannot prove that the vaccine immediately reduced the risk of a heart attack and a stroke.
They requested additional studies to “find out whether this correlation can be associated with the influence of vaccination on the zoster herpes.”
This is the latest study that examines the advantages of the vaccine vaccine for health in addition to the prevention of infection itself. Earlier this year, an independent study showed that the vaccine can reduce The risk of dementia.
The latest results are presented this weekend at the Congress of the European Cardiology Society of 2025 in Madrid.